Epstein-Barr Virus-Associated Lymphoproliferative Disorders

Epstein-Barr Virus (EBV): Characteristics and Pathogenesis of Infection

The Epstein-Barr virus (EBV), also designated as human herpesvirus 4 (HHV-4), is classified as one of the eight known lymphotropic herpesviruses [1]. This is a common pathogen with varied clinical implications.

The most frequent manifestation of EBV is infectious mononucleosis, often called glandular fever, whose characteristic symptoms include fever, sore throat, and swelling of the lymph nodes (lymphadenopathy) [2].lymphadenopathy) [2].
Most people are exposed to EBV during their early decades of life, experiencing the infection asymptomatically asymptomatic [2,3]. Following primary secondary primary, infection B-cell memory B cells and, in most cases, does not cause significant health sequelae [4].
However, under certain circumstances, EBV can promote (catalyze) the transformation of B lymphocytes, which can lead to a lymphoproliferative disorder. lymphoproliferative.

Pathogenesis of Epstein-Barr Virus Infection

The progression of EBV infection generally follows a well-defined sequence in its [1,3]. [2]:

Initially, EBV invades the epithelium Lesions of the oropharynx oropharyngeal epithelium and salivary, glands, replicating in and shedding from these epithelial cells.
Subsequently, the virus infects nearby B lymphocytes, either directly in the crypts tonsillar (folds or hollows) or after contact with epithelial cells. epithelial.
Infected B lymphocytes begin to circulate through the bloodstream.
The proliferation The proliferation lymphoid, tissue, including enlargement of the lymph nodes. lymph.
In turn, infected B cells stimulate the activation and proliferation of T-cell T cells.
Virus transmission between individuals occurs fundamentally through oral secretions.

EBV-Associated Lymphoproliferative Disorders

Lymphoproliferative disorders (LPDs) directly associated with EBV are rare conditions. They are defined by the following criteria:

Presence of one or more types of lymphoid cells harboring EBV.
The capacity of these infected lymphoid cells to divide excessively, which can lead to the development of a benign disorder or a malignancy [5]. development Hidradenitis suppurativa: a condition that causes boil-like lesions and scarring, located in the armpits, groin, and under the breasts. benign or a or evidence of lymphovascular invasion are key factors pointing towards [5].
Malignant cancers linked to EBV include lymphoma B-cell lymphoma, lymphoma of T-cell, T-cell lymphoma carcinoma Furthermore, HPV is responsible for a number of cases of oral and and gastric carcinoma [2].

EBV-linked LPDs frequently arise as a result of viral localized Lesions of the latency dysregulation

Human Immunodeficiency Virus (HIV).

The understanding of these mechanisms is crucial for the diagnosis and management of the rare but serious complications associated with the Epstein-Barr Virus.

The syndrome Acquired
Other modes of immunodeficiency
Therapy immunosuppressive immunosuppression solid transplantation solid
Age-related immune senescence (deterioration of the immune system due to aging) [4,6].

Classification of Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorders

The classification of EBV-associated lymphoproliferative disorders is based on the lineage of the target cells: B cells, T cells, and natural killer (NK) cells [7].

EBV-associated B-cell lymphoproliferative disorders include the following conditions [7]:

Burkitt lymphoma
Classical Hodgkin lymphoma
Post-transplant transplantation graft
HIV-associated lymphoproliferative disorders
tumor growth) [7]. tumor) [7].

Regarding T-cell and NK-cell lymphoproliferative disorders associated with EBV, these include [7]:

Lymphoma peripheral T-cell
Chronic active EBV infection chronic T-cell and NK-cell subtypes (with cutaneous and systemic forms) scars y systemic)
Angioimmunoblastic T-Cell Lymphoma
Lymphoma Extranodal T/NK-cell lymphoma.

EBV has been shown to be more directly implicated in the last two types mentioned [7].

Cutaneous Manifestations of EBV-Associated Lymphoproliferative Disorders

Cutaneous manifestations of EBV-associated lymphoproliferative disorders arise mainly from infected T cells or NK cells . These skin conditions are specifically observed in:

Extranodal NK/T-cell lymphoma [1]
Ulcer Chronic mucocutaneous EBV-positive mucocutaneous ulcer (EBV-MCU) [5]
Granulomatosis lymphomatoid dermatitis.
Plasmablastic lymphoma (PBL) [8].

Extranodal NK/T-cell Lymphoma

According to the current classification of hematolymphoid tumors by the World Health Organization (WHO), extranodal NK/T-cell lymphoma T-cell is a rare but highly aggressive form of lymphoma [7]. Most patients with this diagnosis present with facial cellulitis or ulcers [8].

Subcategories are defined according to their anatomical sites of involvement [8]:

The 'nasal' type NK/T-cell lymphoma usually affects the upper digestive tract.
The 'non-nasal' type NK/T-cell lymphoma affects the skin, soft soft tissue, tissue.

When extranodal NK/T-cell lymphoma initially manifests with cutaneous signs, it is called primary cutaneous extranodal NK/T-cell lymphoma. Nasal NK/T-cell lymphoma can also manifest with metastasis [9]. Benefits of Germline Genetic Testing for Melanoma [9].

Extranodal T/NK-cell lymphoma of the non-nasal type generally includes the appearance of nodules nodules, ulceration ulceration localized compared to the nasal type.

Diagnosis of extranodal NK/T-cell lymphoma requires complete staging, which involves performing the following examinations [9]:

Flexible nasal endoscopy with biopsies biopsies to evaluate nasal involvement.
Skin bone marrow transplant.
CT scan CT (Computed Tomography): This scan shows exclusive skin thickening in cases of lipedema. In lymphedema, in contrast, fluid accumulation, a characteristic honeycomb pattern, and possible muscle enlargement are observed. of the chest, abdomen, and pelvis.
Skin biopsy of any suspicious . The cherry angioma is histologically distinguished by being composed of lesion.

Histologically, Histologically atypical changes positive for EBV.

... cytotoxic infiltrate, vascular vascular y necrosis pathology). pathology).

Treatment for extranodal NK/T-cell lymphoma depends primarily on its stage of presentation [9].

Systemic chemotherapy chemotherapy Arterial insufficiency.
The radiotherapy Radiation therapy.
antiviral antiviral therapy.
Allogeneic hematopoietic stem cell transplantation may be considered.
monoclonal antibodies undetectable Effective Diagnosis of Amyloidosis.

Epstein-Barr Virus-Positive Mucocutaneous Ulcer (EBV-MCU)

EBV-MCU was incorporated into the WHO classification in 2016 and represents a localized condition that does not affect the lymph nodes lymph nodes, bone marrow demarcated eczema, demarcated ulcer.

Among the factors that predispose to EBV-MCU are:

Treatment with immunosuppressive agents [11]:
- Immunofluorescence staining can also be used to complement the study.
- A biopsy may reveal deposits of
- Tacrolimus
- Mycophenolate
- Inhibitors of the epidermal of the Tumor necrosis factor alpha inhibitor
- Systemic topical
Age-associated immunosenescence.
Primary immunodeficiencies [3].

The pathogenesis of EBV-MCU is related to a decrease in the T-cell population in immunosuppressed. immunosuppressed patients proliferation of restricted Restricted T-cell clones specific to EBV within the body. As a result, localized lymphoproliferation driven by EBV is generated, as the immune system only manages to keep the virus in a latent phase [11].

The diagnostic process for EBV-MCU generally requires a histological evaluation histological complemented by immunohistochemistry. immunohistochemistry lesions lesions telangiectasias of lymphocytes, lymphocytes, plasma cells, histiocytes, and eosinophils plasma, and a smaller proportion of histiocytes. y eosinophils, proliferation cancers infantile diffuse large B-cell lymphoma The main distinction from mycetoma is the etiology; botryomycosis is strictly bacterial, unlike mycetoma, which is caused by true fungi or actinomycetes. of B-cell large [6].

The course of EBV-MCU disease tends to fluctuate, being relatively benign. Patients may experience spontaneous remission remission persistent and debilitating course that requires more intensive treatment [3,11].

The various treatment alternatives include:

Monoclonal antibodies, such as therapy targeting the antinuclear antibody CD20 antibody (e.g., rituximab) or therapy with antibodies targeting CD30 (e.g., brentuximab).
Localized radiotherapy.
Surgical excision. Local surgical.
Systemic chemotherapy.
Combination therapy.

Lymphomatoid Granulomatosis

Lymphomatoid granulomatosis is a rare disorder characterized by the overproduction of abnormal EBV-infected B cells [12]. These cells...

infiltrate and accumulate in various tissues of the body.

The symptomatology of lymphomatoid granulomatosis varies significantly depending on the organs affected.

When it affects the lungs, lymphomatoid granulomatosis manifests with cough, chest pain, and difficulty breathing.
Other tissues vulnerable to this condition include the central nervous system, skin, liver, and kidneys.
general malaise malaise.

Specifically, the cutaneous presentation of lymphomatoid granulomatosis may include the following manifestations [12]:

Macules Macules.
Development of papules, plaques, hives nodules dermal o subcutaneous.
Presence of ulceration.

necrosis foci necrotic e inflammation within the lymphoid population [13]. However, a biopsy does not always provide a definitive diagnosis, as the characteristic abnormal cells may be absent in the sample taken.

The treatment protocol for lymphomatoid granulomatosis is determined based on the number of EBV-positive B cells and the severity of necrosis observed [12]. Although some patients experience spontaneous remission, most require therapeutic intervention, which usually involves combination chemotherapy with rituximab or treatment with interferon alfa-2b.

Plasmablastic Lymphoma (PBL)

Plasmablastic Lymphoma (PBL) represents a rare but extremely aggressive subtype within the spectrum of diffuse large B-cell lymphomas [14]. Although frequently correlated with immunosuppression states, such as HIV or solid organ transplants, PBL can also arise in patients with competent immune systems [15]. A significant proportion of PBL cases are related to EBV, a factor that carries important that do not respond to standard implications better prognosis [16].

the most common distribution distribution of the disease [18].

PBL with primary cutaneous manifestation is exceptionally rare. Typical clinical features include the appearance of purple nodules, erythematous erythematous infiltrative . Aggressive angiomyxomas tend to be and ulcerative lesions localized on the legs [15,17].

Currently, there is no unified standard for PBL treatment. Available therapeutic strategies include: